Salix Pharmaceuticals company information, Employees & Contact Information

Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023 Yahoo Finance

Salix To Present Clinical Data At United European Gastroenterology Week Virtual 2020 FirstWord Pharma

SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION PR Newswire

Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals Yahoo Finance

SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY PR Newswire

U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 Yahoo Finance

Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit PR Newswire

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 Yahoo Finance

Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data At PAINWeek 2021 PR Newswire

Bausch Health Announces Updates Related to Norwich XIFAXAN Matters Yahoo Finance

Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022 PR Newswire

Salix Brings Educational Resources on Constipation Into the Homes of Patients and Caregivers for Constipation Awareness Month PR Newswire

SALIX PHARMACEUTICALS WILL PRESENT SCIENTIFIC DATA AT THE SOCIETY OF HOSPITAL MEDICINE CONVERGE 2022 PR Newswire

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease PR Newswire

Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of Inflammatory Bowel Disease PR Newswire

Salix Announces U.S. Launch of PLENVU®, the First and Only 1-Liter PEG Bowel Cleansing Preparation for Colonoscopies PR Newswire

Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio PR Newswire

Salix And Alfasigma Will Initiate Late-Stage Program To Study Rifaximin In Patients With Postoperative Crohn's Disease PR Newswire

Salix Receives FDA Approval For PLENVU®, Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies PR Newswire

Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation PR Newswire

US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA™ (lofexidine) 0.18 Mg Tablets PR Newswire

Compost from willow biomass ( Salix viminalis L.) as a horticultural substrate alternative to peat in the production of vegetable transplants Nature

Salix to Present Clinical Data for XIFAXAN® (RIFAXIMIN) and PLENVU® at the American College of Gastroenterology Annual Meeting PR Newswire

New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix's RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy PR Newswire

New Bowel Prep Option for Colonoscopy Gets FDA Approval Medical Professionals Reference

HALF OF IBS PATIENTS SURVEYED REPORT IBS SYMPTOMS MORE CHALLENGING TO MANAGE IN MultiVu

Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin) ACCESS Newswire

Salix Receives Anticipated FDA Complete Response Letter On XIFAXAN® 550 Mg Tablets Non-C IBS Supplemental New Drug Applica Fierce Biotech

Xifaxan 550mg approved to reduce risk of hepatic encephalopathy Medical Professionals Reference

Energy performance of compressed biomethane gas production from co-digestion of Salix and dairy manure: factoring differences between Salix varieties Biotechnology for Biofuels and Bioproducts

Salix Announces 2024 Gastrointestinal Health Scholars Program By Investing.com Investing.com UK

Bausch Health Completes Major Phase 3 Trial Enrollment for Novel Liver Disease Treatment Stock Titan

Strengthening partnerships and exploring new markets in Madrid FreshPlaza

Salix man faces strangulation charges The Latrobe Bulletin

Apriso approved for ulcerative colitis Medical Professionals Reference

Bausch Health's XIFAXAN Selected for Medicare Price Negotiations Starting 2027 Stock Titan

FDA Advisory Committee Recommends Approval Of Xifaxan Tablets, 550 Mg for Maintenance of Remission of Hepatic Encephalopathy Fierce Biotech

New Documentary, "Wrestling the Monster: Living with Hepatic Encephalopathy," Premieres at American Yahoo

FDA Approves XIFAXAN® 550 Mg Tablets For Reduction In Risk Of Overt Hepatic Encephalopathy (HE) Recurrence Fierce Biotech

FDA Approves Crofelemer as First-Ever Oral Botanical Drug PR Newswire

Energy willow Salix viminalis – biomass where you want it Balkan Green Energy News

Police: Salix man strangled pregnant woman The Tribune-Democrat